{'52WeekChange': 1.2974503,
 'SandP52WeekChange': None,
 'address1': '5217 Winnebago Lane',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 15.1,
 'askSize': 800,
 'averageDailyVolume10Day': 274425,
 'averageVolume': 206219,
 'averageVolume10days': 274425,
 'beta': 1.428011,
 'beta3Year': None,
 'bid': 15.09,
 'bidSize': 800,
 'bookValue': 12.029,
 'category': None,
 'circulatingSupply': None,
 'city': 'Austin',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 16.28,
 'dayLow': 14.691,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -7.839,
 'enterpriseToRevenue': 15.628,
 'enterpriseValue': 198178608,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '512-386-5505',
 'fiftyDayAverage': 14.661715,
 'fiftyTwoWeekHigh': 26.4,
 'fiftyTwoWeekLow': 6.84,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 14080517,
 'forwardEps': 0.13,
 'forwardPE': 117.230774,
 'fromCurrency': None,
 'fullTimeEmployees': 63,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.67336,
 'heldPercentInstitutions': 0.17448,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/xbiotech.com',
 'longBusinessSummary': 'XBiotech Inc., a biopharmaceutical company, '
                        'discovers, develops, and commercializes True Human '
                        'monoclonal antibodies for treating various diseases. '
                        'The company focuses on developing a pipeline of '
                        'antibody therapies for treating oncology, '
                        'inflammatory conditions, and infectious diseases. Its '
                        'product candidates include 514G3, an anti-infective '
                        'antibody that is in Phase II clinical trial for the '
                        'treatment of Staphylococcus Aureus infections; and '
                        'other anti-infectious disease antibodies, which are '
                        'in pre-clinical development to treat Clostridium '
                        'Difficile, influenza, Ebola, and Herpes Varicella '
                        'Zoster (Chickenpox). XBiotech Inc. has a '
                        'collaboration with BioBridge Global for the '
                        'development of potential COVID 19 treatment based on '
                        'natural antibodies from recovered patients. The '
                        'company was founded in 2005 and is headquartered in '
                        'Austin, Texas.',
 'longName': 'XBiotech Inc.',
 'market': 'us_market',
 'marketCap': 439718176,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_216818432',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': 674478976,
 'nextFiscalYearEnd': 1640908800,
 'open': 16.28,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '512-386-2900',
 'previousClose': 16.22,
 'priceHint': 2,
 'priceToBook': 1.2669382,
 'priceToSalesTrailing12Months': 34.675354,
 'profitMargins': 53.18815,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 16.28,
 'regularMarketDayLow': 14.691,
 'regularMarketOpen': 16.28,
 'regularMarketPreviousClose': 16.22,
 'regularMarketPrice': 16.28,
 'regularMarketVolume': 286395,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 28852900,
 'sharesPercentSharesOut': 0.0765,
 'sharesShort': 2206392,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 2122435,
 'shortName': 'XBiotech Inc.',
 'shortPercentOfFloat': 0.15609999,
 'shortRatio': 13.3,
 'startDate': None,
 'state': 'TX',
 'strikePrice': None,
 'symbol': 'XBIT',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': 14.551,
 'trailingPE': 1.0473508,
 'twoHundredDayAverage': 15.077734,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'fb07a30b-f4ae-35af-9fbb-83dba861caeb',
 'volume': 286395,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.xbiotech.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '78744'}